Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy

Alexandra Quinn; Lois Holloway; Nicholas Hardcastle; Wolfgang A. Tomé; Anatoly Rosenfeld; Peter Metcalfe

doi:10.1016/j.radonc.2013.05.019

Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy

Alexandra Quinn, Lois Holloway, Nicholas Hardcastle, Wolfgang A. Tomé, Anatoly Rosenfeld, Peter Metcalfe

Radiation Oncology

Research output: Contribution to journal › Article

9 Scopus citations

Abstract

This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.

Original language	English (US)
Pages (from-to)	266-268
Number of pages	3
Journal	Radiotherapy and Oncology
Volume	108
Issue number	2
DOIs	https://doi.org/10.1016/j.radonc.2013.05.019
State	Published - Aug 1 2013

Keywords

Breast
CT
Cancer risk
Dose
Megavoltage
Tomotherapy

ASJC Scopus subject areas

Hematology
Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.radonc.2013.05.019

Fingerprint Dive into the research topics of 'Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy'. Together they form a unique fingerprint.

Cite this

Quinn, A., Holloway, L., Hardcastle, N., Tomé, W. A., Rosenfeld, A., & Metcalfe, P. (2013). Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy. Radiotherapy and Oncology, 108(2), 266-268. https://doi.org/10.1016/j.radonc.2013.05.019

Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy. / Quinn, Alexandra; Holloway, Lois; Hardcastle, Nicholas; Tomé, Wolfgang A.; Rosenfeld, Anatoly; Metcalfe, Peter.

In: Radiotherapy and Oncology, Vol. 108, No. 2, 01.08.2013, p. 266-268.

Research output: Contribution to journal › Article

@article{82d2388091744f3b98e7095663968aa3,

title = "Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy",

abstract = "This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.",

keywords = "Breast, CT, Cancer risk, Dose, Megavoltage, Tomotherapy",

author = "Alexandra Quinn and Lois Holloway and Nicholas Hardcastle and Tom{\'e}, {Wolfgang A.} and Anatoly Rosenfeld and Peter Metcalfe",

year = "2013",

month = aug,

day = "1",

doi = "10.1016/j.radonc.2013.05.019",

language = "English (US)",

volume = "108",

pages = "266--268",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy

AU - Quinn, Alexandra

AU - Holloway, Lois

AU - Hardcastle, Nicholas

AU - Tomé, Wolfgang A.

AU - Rosenfeld, Anatoly

AU - Metcalfe, Peter

PY - 2013/8/1

Y1 - 2013/8/1

N2 - This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.

AB - This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.

KW - Breast

KW - CT

KW - Cancer risk

KW - Dose

KW - Megavoltage

KW - Tomotherapy

UR - http://www.scopus.com/inward/record.url?scp=84885387773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885387773&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2013.05.019

DO - 10.1016/j.radonc.2013.05.019

M3 - Article

C2 - 23849173

AN - SCOPUS:84885387773

VL - 108

SP - 266

EP - 268

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -